Autobio Diagnostics and Subsidiary Secure Four Medical Device Registrations

Stock News
05/19

Autobio Diagnostics Co.,Ltd. (603658.SH) has announced that the company and its wholly-owned subsidiary, Autobio Instruments (Zhengzhou) Co., Ltd., recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration. A total of four products have obtained these registrations. They are: the fully automated chemiluminescence immunoassay analyzer (models: AutoLumo A6900, AutoLumo A9000, AutoLumo A9600), the Epstein-Barr virus capsid antigen IgM antibody detection kit (magnetic particle chemiluminescence method), the Mycoplasma pneumoniae nucleic acid and drug-resistant mutation site detection kit (PCR-fluorescence probe method), and the Interleukin-17A detection kit (magnetic particle chemiluminescence method).

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10